#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ornithine transcarbamoylase deficiency Systemic candida B-cell type acute leukaemia Synovitis Cutaneous T-cell lymphoma stage I Stargardt's disease Interstitial lung disease Follicular lymphoma Cutaneous T-cell lymphoma stage II Autoimmune hepatitis Pyruvate dehydrogenase complex deficiency Hyperadrenocorticism Gestational trophoblastic tumour KBG syndrome Stress cardiomyopathy More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Life with Disease Choroid melanoma – Treatment Haemophilia A with anti factor VIII – Treatment Carcinoid syndrome – Treatment Myxofibrosarcoma – Treatment Gastrointestinal stromal tumour – Life with Disease Idiopathic inflammatory myopathy – Basic Information Familial haemophagocytic lymphohistiocytosis Angiosarcoma metastatic – Diagnostics Adrenogenital syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMLENETUG Wt1 Mrna Dc Ivabradine Acenocoumarol VENT-03 Isaralgagene Civaparvovec Gadoquatrane HUPERZINE A Minoxidil Tiotropium Goserelin Acetate Cinchocaine Hydrochloride Volrustomig Tisagenlecleucel STREPTOCOCCUS PYOGENES Levothyroxine Mercaptamine Deferoxamine INSULIN DETEMIR Vinflunine More therapies…

    Learn about Your Condition

    Multiple sclerosis Transient ischaemic attack Acarodermatitis Plasma cell leukaemia Eye inflammation Peripheral artery stenosis Endocarditis enterococcal Hip arthroplasty Insomnia Kearns-Sayre syndrome Liposarcoma metastatic Inborn error of metabolism Neuropathic arthropathy Alagille syndrome Diabetic retinal oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Enzalutamide
    • Apalutamide
    Sweden

  • Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Gemcitabine
    • Pegfilgrastim
    • Carboplatin
    Austria Belgium Czechia France Germany Ireland +5

  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Saruparib
    Austria Belgium Finland France Germany Hungary +5

  • Study of enfortumab vedotin and avelumab for patients with advanced or metastatic penile cancer that has spread or cannot be removed by surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile squamous cell carcinoma
    Investigated Drugs:
    • Enfortumab Vedotin
    • Avelumab
    Germany

  • Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • NADOFARAGENE FIRADENOVEC
    • Docetaxel
    • Gemcitabine Hydrochloride
    Czechia Denmark France Poland Spain

  • Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Colorectal cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Aldesleukin
    • Mesna
    • Cyclophosphamide Monohydrate
    Germany
Previous Page
1 2 3 4 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!